Eur J Immunol 1997, 27:3135–3142 PubMedCrossRef 19 Bellinghausen

Eur J Immunol 1997, 27:3135–3142.PubMedCrossRef 19. Bellinghausen I, Brand U, Knop J, Saloga J: Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol 2000, 105:988–996.PubMedCrossRef 20. Graham FL, Smiley J, Russell WC, Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977, 36:59–74.PubMedCrossRef 21. Bénard J, da Silva J, de

Blois MC, Boyer P, Duvillard P, Chiric E, Riou G: Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. SBI-0206965 Cancer Res 1985, 45:4970–4979.PubMed 22. Ross R, Ross XL, Schwing J, Längin T, Reske-Kunz AB: The actin-bundling

protein fascin is involved in the formation of dendritic processes in maturing epidermal Langerhans cells. J Immunol 1998, 160:3776–3782.PubMed 23. Al-Alwan MM, Rowden G, Lee TD, West KA: Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol 2001, 166:338–345.PubMed 24. Gunzer M, Schäfer A, Borgmann S, Grabbe S, Zänker Belnacasan chemical structure KS, Bröcker EB, Kämpgen E, Friedl P: Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity 2000, 13:323–332.PubMedCrossRef 25. Breckpot K, Heirman C, Neyns B, Thielemans K: Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells. J Gene Med 2004, 6:1175–1188.PubMedCrossRef 26. Fiorentino L, Stehlik C, Oliveira V, Ariza ME, Godzik A, Reed JC: A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J Biol Chem 2002, 277:35333–35340.PubMedCrossRef 27. Li R, Mouillesseaux KP, Montoya D,

Cruz D, Gharavi N, Dun M, Koroniak L, Berliner JA: Identification oxyclozanide of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ Res 2006, 98:642–650.PubMedCrossRef 28. Neumann M, Fries HW, Scheicher C, Keikavoussi P, Kolb-Mäurer A, Bröcker EB, Serfling E, Kämpgen E: Differential expression of Rel/NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 2000, 95:277–285.PubMed 29. Doyle SL, Jefferies CA, O’Neill LA: Bruton’s check details tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide. J Biol Chem 2005, 280:23496–23501.PubMedCrossRef 30. Scott ML, Fujita T, Liou HC, Nolan GP, Baltimore D: The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Gen Dev 1993, 7:1266–1276.CrossRef 31. Li M, Zhang X, Zheng X, Lian D, Zhang ZX, Ge W, Yang J, Vladau C, Suzuki M, Chen D, Zhong R, Garcia B, Jevnikar AM, Min WP: Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference.

Comments are closed.